Condition
Oropharyngeal Cancers
Total Trials
6
Recruiting
2
Active
3
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Completed1
Terminated1
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06902623Not ApplicableRecruitingPrimary
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
NCT07241273Not ApplicableNot Yet Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
NCT06682494Not ApplicableRecruiting
Enhancing Oral Cancer Awareness
NCT06806683Active Not Recruiting
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
NCT06701058CompletedPrimary
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
NCT00797446TerminatedPrimary
Photon/Proton Radiation Therapy for Oropharyngeal Cancers
Showing all 6 trials